Europe · Markets & Finance · Le Figaro Économie

Pourquoi Sanofi renouvelle à prix d’or son alliance avec la biotech américaine Regeneron

Published by Le Figaro Économie · France 7 h ago

DÉCRYPTAGE - Le laboratoire français, qui doit regarnir son portefeuille de médicaments, débourse jusqu’à 8 milliards d’euros.

Read the full article on Le Figaro Économie Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.lefigaro.fr)

Also worth reading

Financial Times

US sanctions Kremlin-backed fintech A7 for allegedly assisting Iran

UK becomes first major economy to pay 6% to borrow since eurozone crisis as bond market rout pushes yields to highest since 1998

Diesel crisis: UK minister holds emergency talks with US Energy Secretary

Nike misses revenue consensus, shares down 4% to new 12-year low

Reuters Markets

Indian share benchmarks set for longest weekly losing run in 25 years

Reuters Sustainability

Balenciaga shows colourful jackets and minimalist sneakers in Piccioli's summer 2027 collection